(Q40945896)

25 September 2017

1 reference

title

Natural killer cells and cancer (English)

1 reference

25 September 2017

Brittenden J

1

1 reference

25 September 2017

Heys SD

series ordinal

2

1 reference

25 September 2017

Ross J

series ordinal

3

1 reference

25 September 2017

Eremin O

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

77

1 reference

25 September 2017

issue

7

1 reference

25 September 2017

page(s)

1226-1243

1 reference

Biology of natural killer cells

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Response of resting human peripheral blood natural killer cells to interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Mechanisms of target cell killing by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Natural killer cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Recognition structures on natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine-activated killer cells, natural killer cells and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Cell-mediated cytotoxic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Development of natural killer cells in human thymocyte culture: regulation by accessory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Age-associated alterations in human natural killer cells. 2. Increased frequency of selective NK subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Natural killer cells: their roles in defenses against disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Role of NK cells in tumour growth and metastasis in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Low natural-killer-cell activity in familial melanoma patients and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Influence of serum derived from patients with head and neck cancer on natural killer cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

High interferon titer and defective NK-cell activity in the circulation of nasopharyngeal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Reduced natural killer cell activity and IL-2 production in malnourished cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Interleukin-2-inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

In vitro natural killer and lymphokine-activated killer activity in patients with bronchogenic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Natural killer cells and metastases from pharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

MHC-unrestricted cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

An explanation of the variable clinical response to interleukin 2 and LAK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Tumour-associated proliferative responses in vitro of regional lymph nodes draining solid cancers in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Expression of a suppressive p15E-related epitope in colorectal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Need for immunologic stimulators during immunosuppression produced by major cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Natural killer cell activity during premedication, anaesthesia and surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Detrimental effects of perioperative blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Peri-operative modulation of cellular immunity in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Immune impairment and metastatic tumor growth.The need for an immunorestorative drug as an adjunct to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Estrous influence on surgical cure of a mouse breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Comparison of natural killer activity during the first and second halves of the menstrual cycle in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Hormonal modulation of human natural killer cell activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Decline of Natural Killer Cell Activity in Sublethally Irradiated Mice2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Susceptibility to Influenza A Virus Infection in Mice Immunosuppressed with Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Paradoxical effects of 5-FU/folinic acid on lymphokine-activated killer (LAK) cell induction in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

P-glycoprotein, multidrug resistance and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

The immunotherapy of human cancer with interleukin 2: present status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Interleukin 2 therapy: current role in surgical oncological practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

The impact of interleukin-2 on survival in renal cancer: a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

The clinical experience with interleukin-2 in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Clinical application of cytokines for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Cytokines in tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

The role of cytokines in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Subcutaneous recombinant interleukin-2 and alpha-interferon in patients with advanced renal cell carcinoma: results of a multicenter Phase II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Interleukin-2: solid-tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

The Role of Natural Killer Cells in Immune Surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

A new immunodeficiency disorder in humans involving NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960401%2977%3A7%3C1226%3A%3AAID-CNCR2%3E3.0.CO%3B2-G

10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference